Fibrin glue for wound repair: Facts and fancy

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1003-1006

  Clark, Richard A F ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Cell migration; Fibrin sealant; Fibronectin; Wound healing

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13A; BLOOD DERIVATIVE; FIBRIN; FIBRIN GLUE; FIBRINOGEN VARIANT; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GLYCOSAMINOGLYCAN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PLATELET DERIVED GROWTH FACTOR; SEALANT; SOMATOMEDIN BINDING PROTEIN 3; THROMBIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN; VITRONECTIN;

BLOOD COMPONENT; CLINICAL TRIAL; CRYOPRECIPITATION; DRUG EFFECT; DRUG PREFERENCE; FIBRIN CLOT; FIBRIN METABOLISM; HEMOSTASIS; HUMAN; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURGICAL WOUND; TISSUE REPAIR; UNITED KINGDOM; UNITED STATES; WOUND; WOUND HEALING;

EID: 0347674327     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-08-0526     Document Type: Review

References (52)

1. Drew AF, Liu H, Davidson JM, et al. Wound-healing defects in mice lacking fibrinogen. Blood 2001; 97: 3691-8.
2. Chan JC, Duszczyszyn DA, Castellino FJ, et al. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol 2001; 159: 1681-8.
3. Clark RAF. Fibrin is a many splendored thing. J Invest Dermatol 2003; 121: in press.
4. Clark RAF. Fibrin and wound healing. Ann N Y Acad Sci 2001; 936: 355-67.
5. Van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci 2001; 936: 426-37.
6. Kawase T, Okuda K, Wolff LF, et al. Platelet-rich plasma-derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Peroiodontol 2003; 74: 858-64.
7. Nien YD, Han YP, Tawai B, et al. Fibrinogen inhibits fibroblast-mediated contracton of collagen. Wound Repair Regen 2003; 11: 380-5.
8. Geer DJ, Swartz DD, Andreadis ST. Fibrin Promotes Migration in a Three-Dimensional In Vitro Model of Wound Regeneration. 2002; 8: 787-98.
9. Clark RAF. Fibrin sealant in wound repair: A systematic survey of the literature. Expert Opin Investig Drugs 2000; 9: 2371-92.
10. De Virgilio C, Dubrow T, Sheppard BB, et al. Fibrin glue inhibits intra-abdominal adhesion formation. Arch Surg 1990; 125: 1378-81; discussion 1381-2.
11. Sheppard BB, De Virgilio C, Bleiweis M, et al. Inhibition of intra-abdominal adhesions: Fibrin glue in a long term model. Am Surg 1993; 59: 786-90.
12. Takeuchi H, Toyonari Y, Mitsuhashi N, et al. Effects of fibrin glue on postsurgical adhesions after uterine or ovarian surgery in rabbits. J Obstet Gynaecol Res 1997; 23: 479-84.
13. Frykman E, Jacobsson S, Widenfalk B. Fibrin sealant in prevention of flexor tendon adhesions: An experimental study in the rabbit. J Hand Surg [Am] 1993; 18: 68-75.
14. Moro H, Hayashi J, Ohzeki H, et al. The effect of fibrin glue on inhibition of pericardial adhesions. Jpn J Thorac Cardiovasc Surg 1999; 47: 79-84.
15. Donnez J, Nisolle M. Laparoscopic management of large ovarian endometrial cyst: Use of fibrin sealant. J Gynecol Surg 1991; 7: 163-6.
16. Eroglu E, Oral S, Unal E, et al. Reducing seroma formation with fibrin glue in an animal mastectomy model. Eur J Surg Oncol 1996; 22: 137-9.
17. Harada RN, Pressler VM, McNamara JJ. Fibrin glue reduces seroma formation in the rat after mastectomy. Surg Gynecol Obstet 1992; 175: 450-4.
18. Sanders RP, Goodman NC, Amiss LR, Jr., et al. Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention. J Surg Res 1996; 61: 65-70.
19. Uden P, Aspegren K, Balldin G, et al. Fibrin adhesive in radical mastectomy. Eur J Surg 1983; 159:263-5.
20. Vaxman F, Kolbe A, Stricher F, et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res 1995; 27: 346-52.
21. Gilly FN, Francois Y, Sayag-Beaujard AC, et al. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: Prospective randomized trial. Eur Surg Res 1998; 30: 439-43.
22. Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: A randomized prospective trial. Am Surg 1997: 63: 97-102.
23. Dinsmore RC, Harris JA. Gustafson RJ. Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: A prospective randomized trial. Am Surg 2000; 66: 982-5.
24. Langer S, Guenther JM, DiFronzo LA. Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer? Am Surg 2003; 69: 77-81.
25. Moore M, Burak WE, Jr., Nelson E, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: A randomized prospective clinical trial. J Am Coll Surg 2001; 192: 591-9.
26. Giovannacci L, Renggli JC, Eugster T, et al. Reduction of groin lymphatic complications by application of fibrin glue: Preliminary results of a randomized study. Ann Vasc Surg 2001; 15:182-5.
27. Scholz HS, Petru E, Benedicic C, et al. Fibrin application for preventing lymphocysts after retroperitoneal lymphadenectomy in patients with gynecologic malignancies. Gynecol Oncol 2002; 84: 43-6.
28. Yamada KM, Clark RAF. Provisional matrix. In Molecular and Cellular Biology of Wound Repair. Clark, R. A. F., editor. Plenum, New York. 1996; 51-93.
29. Clark RAF. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 1990; 94(Suppl): 128S-134S.
30. Clark RAF, An J.-Q, Greiling D, et al. Fibroblast migration on fibronectin requires 3 distinct functional domains. J Invest Dermatol 2003; in press.
31. Herrick SE, Sloan P, McGurk M, et al. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Path 1992; 141: 1085-95.
32. Greiling D, Clark RAF. Fibronectin provides a conduit for fibroblast transmigration from a collagen gel into a fibrin gel. J Cell Sci 1997; 110: 861-70.
33. Mosesson MW, Umfleet R. The cold insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold insoluble fraction components. J Biol Chem 1970; 245; 5726-36.
34. Clark RAF, Lanigan JM, DellaPelle P, et al. Fibronectin and fibrin(ogen) provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-9.
35. Tuszynski GP, Srivastava S, Switalska HI, et al. The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction. J Biol Chem 1985; 260: 12240-5.
36. Dixit VM, Grant GA, Frazier WA, et al. Isolation of the fibrinogen-binding region of platelet thrombospondin. Biochem Biophys Res Commun 1984; 119: 1075-81.
37. Bacon-Baguley T, Ogilvie ML, Gartner TK, et al. Thrombospondin binding to specific sequences within the A alpha- and B beta-chains of fibrinogen. J Biol Chem 1990; 265: 2317-23.
38. Preissner KT, Jenne D. Vitronectins. A new molecular connection in haemostasis. Thromb Haemost 1991; 66: 189-94.
39. Odrljin TM, Shainoff JR, Lawrence SO, et al. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain. Blood 1996; 88: 2050-61.
40. Castellino FJ, Strickland DK, Morris JP, et al. Enhancement of the streptokinase-induced activation of human plasminogen by human fibrinogen and human fibrinogen fragment D1. Ann NY Acad Sci 1983; 408: 595-601.
41. Thorsen S, Glas-Greenwalt P, Astrup T. Difference in the binding to fibrin of urokinase and tissue plasminogen activator. Thromb Pathol Haem 1972; 28: 65-74.
42. Wagner OF, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 1989; 70: 1645-53.
43. Liu CY, Nossel HL, Kaplan KL. The binding of thrombin by fibrin. J Biol Chem 1979; 254: 10421-5.
44. Wilner GD, Danitz MP, Mudd MS, et al. Selective immobilization of alpha-thrombin by surface-bound fibrin. J Lab Clin Med 1981; 97: 403-11.
45. Kaminski M, McDonagh J. Studies on the mechanism of thrombin interaction with fibrin. J Biol Chem 1983; 258: 10530-5.
46. Siebenlist KR, DiOrio JP, Budzynski AZ, et al. The polymerization and thrombin-binding properties of des-(Bb1-42)-fibrin. J Biol Chem 1990; 265: 18650-5.
47. Sahni A, Odrljin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 1998; 273: 7554-9.
48. Campbell PG, Durham SK, Hayes JD, et al. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem 1999; 274: 30215-21.
49. Sahni A, Francis C W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-8.
50. Sakata Y, Aoki N. Cross-linking of α2-plasma inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 1980; 65: 290-7.
51. Zisch AH, Schenk JC, Sakiyama-Elbert SE. Covalently conjugated VEGF-fibrin matricess for endothelialization. J Control Release 2001; 72: 101-13.
52. Wong C, Inman E, Spaethe R. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 2003; 89: 573-82.